Back to Ovarian Cancer
NCT02389088
NCT02389088
Who may be able to join
Who might be able to join this trial:
- You have been diagnosed with Polycystic Ovary Syndrome (PCOS), based on having irregular periods and signs (either from symptoms or blood tests) of higher-than-normal male hormone levels.
- You have not taken any hormonal treatments (such as birth control pills) or the medication metformin for at least 2 months before the study begins.
Who may not be able to join:
- Women whose hemoglobin (a measure of red blood cells in the blood) is below 11 g/dl at the initial screening appointment.
- Women who have a thyroid condition that is not currently being treated.
- Women who are pregnant.
- Women with a Body Mass Index (BMI) — a measure of body weight relative to height — above 37.
- Women who are known to have an allergy or sensitivity to the medication being used in this study (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Trial details
Status
Completed
Phase
Not Applicable
Sponsor
University of California, San Diego
Registry
clinicaltrials_gov
Start date
1 April 2006
Est. completion
1 January 2013
Primary endpoints
Estradiol During Phase I and Phase II; Inhibin B During Phase I and Phase II; LH and FSH During Phase I and Phase II; Testosterone, Androstenedione and 17-OH Progesterone During Phase I and Phase II
Can't join this trial?
Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.